Suchergebnisse - "Allaire, Manon"

PubPharm (86)

1

Feasibility of Liver Transplantation after 90Y Radioembolization : Lessons from a Radiation Protection Incident

enthalten in: Health physics | 2024

von Soret, M. | Maisonobe, J. | Maksud, P. | +6

2

Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Sultanik, P. | Campani, C. | Larrey, E. | +9

3

No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Copil, F. | Campani, C. | Lequoy, M. | +9

4

Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC : A promising approach for improved survival

enthalten in: Clinics and research in hepatology and gastroenterology | 2024

von Mejait, A. | Roux, C. | Soret, M. | +8

5

Comment on Wu et al. Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma. Cancers 2023, 15, 2480

enthalten in: Cancers | 2024

von Allaire, M. | Thabut, D.

6

Portal hypertension and variceal bleeding in patients with liver cancer : Evidence gaps for prevention and management

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Allaire, M. | Thabut, D.

7

Reply : Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Allaire, M. | Thabut, D.

8

Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Campani, C. | Vallot, A. | Ghannouchi, H. | +12

9

No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC

enthalten in: Liver International | 2024

von Copil, F. | Campani, C. | Lequoy, M. | +9

10

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

enthalten in: Nature communications | 2023

von Calderaro, J. | Ghaffari Laleh, N. | Zeng, Q. | +82

1
2
3
4
5
6
7
8
9
Nächster »
[9]